| Document |
Document Title |
|
WO/2007/102594A1 |
A polymer complex which has two or more kinds of pores capable of selectively taking up and/or releasing and/or transporting specific compounds ranging from gaseous low molecules to high molecules such as proteins and other living-body-d...
|
|
WO/2007/101844A1 |
A process for the removal by distillation of dinitrotoluene from process wastewater from the preparation of dinitrotoluene by nitration of toluene by means of nitrating acid, which is characterized in that the process wastewater is broug...
|
|
WO/2007/103595A2 |
This invention relates to processes for making nitro compounds derived from C2-C30 unsaturated fatty acids; C2-C30 unsaturated fatty oils; esters derived from the reaction of C1-C20 alcohols with unsaturated C2-C30 fatty acids; C2-C20 po...
|
|
WO/2007/094327A1 |
[PROBLEMS] To provide a method of stably isolating an aldehyde and a method accompanied by the generation of waste in a reduced amount in the process of producing an aldehyde by oxidizing the corresponding primary alcohol or its alkyl et...
|
|
WO/2007/091658A1 |
The object is to provide a novel process for production of an optically active allyl compound which is useful as an intermediate raw material for the production of a pharmaceutical or the like. Disclosed is a process for production of an...
|
|
WO/2007/087816A1 |
The invention relates to the nitration of aromatic or heteroaromatic compounds, wherein an activated aromatic or heteroaromatic compound and a nitrating agent, in the presence, if desired, of a solvent, are mixed intensely in a microreac...
|
|
WO/2007/074789A1 |
Disclosed is a novel process intermediate represented by the general formula (1) or (2): wherein X represents a halogen atom, a cyano group or the like; Y represents a halogen atom, a cyano group or the like; R1 represents a C1-C6 haloal...
|
|
WO/2007/071649A2 |
The invention relates to the salts of styphnic acid, to methods for producing the same and to their use.
|
|
WO/2007/072679A1 |
A process for producing 2,4-difluoronitrobenzene characterized by reacting 2,4-dichloronitrobenzene with potassium fluoride in the presence of a sulfone compound represented by the formula (1): R1-SO2-R2 (1) (wherein R1 and R2 are the sa...
|
|
WO/2007/066828A1 |
Disclosed are a process for producing a compound (IIa) shown below or a compound (IIb) shown below; a process for producing a compound (IIIa) shown below or a compound (IIIb) shown below; a process for producing a compound (Va) shown bel...
|
|
WO/2007/063028A2 |
The invention relates to methods for producing sulfonamides of formula I, wherein the variables have the designations cited in the description, by reacting m-nitro-benzoic acid chlorides of formula II with aminosulfons of formula III, un...
|
|
WO/2007/054257A2 |
The present invention makes reference to new indene derivatives with general formula (I), as well as to their preparation procedures, their application as medicament and the pharmaceutical compositions containing them. The new compounds ...
|
|
WO/2007/048556A1 |
The invention relates to a fungicidally active compound of formula (I): where Het is a 5- or 6-membered heterocyclic ring containing one to three heteroatoms, each independently selected from oxygen, nitrogen and sulphur, the ring being ...
|
|
WO/2007/039125A2 |
The invention provides an optically active form of the compound of formula (I), or a pharmaceutically acceptable ester, amide, solvate or salt thereof, including a salt of such an ester or amide, and a solvate of such an ester, amide or ...
|
|
WO/2007/031323A1 |
The present invention relates to a process for the preparation of compounds of formula (I) wherein R1 and R2 are each independently of the other hydrogen or C1-C5alkyl and R3 is CF3or CF2H, by a) reaction of a compound of formula (Il) wh...
|
|
WO/2007/023496A2 |
Process of preparing high purity bromopicrin, and high purity bromopicrin produced therefrom. Providing a mixture of nitromethane and bromine, and preferably water, and absent of organic solvent. Adding an aqueous solution of an alkaline...
|
|
WO/2007/020227A1 |
The invention relates to a method for producing betamimetics of formula (I), in which n represents 1 or 2; R1 represents hydrogen, halogen, C1-4 alkyl or O-C1-4 alkyl; R2 represents hydrogen, halogen, C1-4 alkyl or O-C1-4 alkyl, and; R3 ...
|
|
WO/2007/015259A2 |
The present invention discloses a process for efficient production of 2-amino-5- hydroxypropiophenone corresponding to the AB ring part of camptothecin (CPT) skelton, which is a key intermediate useful for the total synthesis of camptoth...
|
|
WO/2007/013201A1 |
A zinc fluorescent probe that excels in water solubility, enabling observing with high sensitivity of any change of intracellular zinc ion level ratiometrically with the use of a single excited wavelength; a process for producing the sam...
|
|
WO/2007/013681A1 |
Disclosed are: a guanidine-thiourea compound which can realize the production of a desired nitro alcohol through Henry reaction at a high optical purity and a high yield with reduced environmental impact; and a process for producing a ni...
|
|
WO/2007/010546A1 |
Novel benzoquinone-derived compounds and polymorphs and prodrugs thereof, geometric or optical isomers thereof, and pharmaceutically acceptable esters, ethers, carbamates, oximes of such compounds, polymorphs, prodrugs and isomers are pr...
|
|
WO/2007/000998A1 |
It has been demanded to improve the poor solubility of curcumin to develop an anti-tumor compound capable of inhibiting the proliferation of various cancer cells at a low concentration. Thus, disclosed is a novel synthetic compound, a bi...
|
|
WO/2006/133823A1 |
Benzanilides of the formula: (I) in which X represents hydrogen, halogen, nitro, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl or C1-6 alkylsulfonyloxy; Y represents halogen or C1-6 alkyl; R1 represents C1-6 alkyl, C1-6 alkylthi...
|
|
WO/2006/132436A1 |
A compound represented by the general formula (1') or a salt thereof; and a therapeutic or prophylactic agent for a glucocorticoid-related condition or an 11βHSD1 inhibitor comprising the compound of the salt thereof: (1') wherein the r...
|
|
WO/2006/125593A1 |
A compound of formula (I); in free or pharmaceutically acceptable salt form, where R1, R2, R3, R4, R5, m, n, w, X, Y and Q have the meanings as indicated in the specification, are useful for treating conditions mediated by the CRTh2 rece...
|
|
WO/2006/120031A1 |
Process for the preparation of a carboxamide derivative of general formula (I) or a salt thereof Intermediates for preparing this compound.
|
|
WO/2006/098398A1 |
A method of synthesizing a compound through a coupling reaction using a palladium-containing perovskite-type composite oxide as a catalyst. The catalyst retains its activity even when recovered after the reaction and repeatedly used. The...
|
|
WO/2006/093728A2 |
The present invention is directed to a process of maximizing the solubility of a nonelectrolyte solute in a solvent by operating within an optimal temperature range at conditions wherein the nonelectrolyte solute is not a pure liquid. In...
|
|
WO/2006/092429A1 |
The invention relates to a method for producing substituted biphenyls (I) in which: R1 = nitro, amino or NHR3: R2 = CN, NO2, halogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6-alkoxy, C1-C6 alkyl halide, C1-C6 alkylcarbonyl or phe...
|
|
WO/2006/090210A1 |
The object of the invention is the preparation of 2-chloro-4-fluoro-5-nitrobenzoic acid and derivatives thereof, by nitration of 2-chloro-4-fuorobenzotrichloride and the conversion of the novel synthetic intermediate thus obtained into i...
|
|
WO/2006/087222A1 |
The present invention relates to a process for the preparation of compounds of formula (I) wherein the substituents are as defined in claim 1 , by a) reaction of a compound of formula (II) wherein the substituents are as defined in claim...
|
|
WO/2006/087221A1 |
The present invention relates to a process for the preparation of compounds of formula (I) wherein the substituents are as defined in claim 1, by reaction of a compound of formula (II) wherein the substituents are as defined in claim 1, ...
|
|
WO/2006/086683A2 |
The present invention relates to compositions comprising HFC-63-14mcee (1, 1, 1, 1, 2, 2, 3, 4, 5, 5, 6, 6, 7, 7, 7,- tetradecafluoroheptane). The compositions may be azeotropic or azeotrope-like and are useful in cleaning applications, ...
|
|
WO/2006/082452A1 |
The application relates to optically active compounds of the general formula (I): Formula (I) wherein R means a hydrogen atom or a straight or branched alkyl group containing 1-4 carbon atoms, R1 means a hydrogen atom or a straight or br...
|
|
WO/2006/082166A1 |
The invention describes a composition comprising a) an organic material which is susceptible to oxidative, thermal or light-induced degra- dation, and b) at least one melt additive of a compound of the formula I R1 (I) R3 X R2 wherein th...
|
|
WO/2006/079857A1 |
The invention relates to compounds of the general formula (I), wherein R stands for nitro group or -COOR1 group, wherein R1 stands for hydrogen atom or for C1-4 straight or branched alkyl group, R2 stands for hydrogen atom, C1-4 straight...
|
|
WO/2006/076821A1 |
Use of a compound of formula 1 as malodour neutraliser [insert formula here] wherein A, B, Y and Y have the same meaning as given in the specification, and personal care products comprising the same.
|
|
WO/2006/076415A2 |
The application discloses a novel process for the preparation of himbacine analogs useful as thrombin receptor antagonists. The process is based in part on the use of a base-promoted dynamic epimerization of a chiral nitro center. The ch...
|
|
WO/2006/063728A1 |
The invention relates to nitroalkanes that are substituted by monoheteroatoms and that are devoid of enantiomers or are rich in enantiomers and to a method for producing said substances. According to said method, nitroalkanes, which are ...
|
|
WO/2006/056535A1 |
A process for preparing a compound of formula (I) X-(CH2)n-ONO2 (I) wherein: X is a halogen atom selected from Cl, Br, I; n is an integer from 3 to 6; said process comprising the slow addition of a compound of formula (II) X-(CH2)n-OH (I...
|
|
WO/2006/057323A1 |
A composition for amyloid-associated disease diagnosis, comprising any of a flavone derivative, a chalcone derivative, a styrylchromone derivative and a coumarin derivative. These derivative compounds simultaneously have a high binding s...
|
|
WO/2006/047888A1 |
Disclosed are processes for the preparation of 2-substituted indole compounds wherein the 2-substituent comprises an R4 group, wherein R4 is selected from the group consisting of monocyclic aromatic, polycyclic aromatic, monocyclic heter...
|
|
WO/2006/046593A1 |
Disclosed is an excellent LXR modulator. Specifically disclosed is a compound represented by the general formula (I) below or the like. (I) [In the formula, R1 represents a -COR9 (wherein R9 represents an alkyl, optionally substituted al...
|
|
WO/2006/044379A2 |
The present invention relates to compounds capable of acting as androgen receptor, antagonists, pharmaceutical formulations containing the same, and methods of use thereof. Such uses include, but are not limited to, use as antitumor agen...
|
|
WO/2006/040652A2 |
The present invention relates to a method of preparing N-(3,5-dichloropyrid-4-yl)-4-difluoromethoxy-8-methanesulfon
amido-dibenzo[b,d]furan-1-carboxamide and pharmaeutically acceptable salts thereof, such as its sodium salt, and novel in...
|
|
WO/2006/029532A1 |
Nitrate esters and methods for mitigating neurodegeneration, affecting neuroprotection, affecting cognition enhancement, and/or preventing or mitigating tissue and/or cellular damage in a subject are described. Neurological or cognitive ...
|
|
WO/2006/019955A2 |
Disclosed herein are antiviral compounds, such as anti-human cytomegalovirus antiviral compounds, pharmaceutical compositions and antiviral methods.
|
|
WO/2005/123667A1 |
Compounds of formula (I) wherein the substituents are as defined in claim 1, are suitable for use as herbicides.
|
|
WO/2005/123636A1 |
The invention relates to alkyl benzoles comprising branched, poly or perhalogenated alkyl groups. Said alkyl benzoles can be produced from the corresponding alkyl compounds by chlororination and subsequently fluorination. Optionally it i...
|
|
WO/2005/119315A2 |
In one aspect, the present invention provides a hyperpolarizable organic chromophore. The chromophore is a nonlinear optically active compound that includes a &pgr -donor conjugated to a &pgr -acceptor through a &pgr -electron conjugated...
|
